{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:01Z","timestamp":1740108121510,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T00:00:00Z","timestamp":1611619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>This study explored the impact of ethnicity on time-to-clinic, time-to-treatment and rates of vision loss in people referred to hospital with diabetic eye disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A survival analysis was performed on all referrals from an inner-city diabetic eye screening programme to a tertiary hospital eye service between 1 October 2013 and 31 December 2017. Exclusion criteria were failure to attend hospital, distance visual acuity in both eyes too low to quantify with the Early Treatment Diabetic Retinopathy Study (ETDRS) letter chart and treatment received prior to referral. Demographic and screening grade data were collected at the point of referral. Small-area statistics and census data were used to calculate indices of multiple deprivation. The main outcome measures were time taken from the date of referral for an individual to achieve the following: (1) attend the first hospital clinic appointment; (2) receive the first macular laser, intravitreal anti-vascular endothelial growth factor injection or pan-retinal photocoagulation treatment, in either eye; and (3) lose at least ten ETDRS letters of distance visual acuity, in either eye.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 2062 referrals, 1676 individuals were included. Mean age (\u00b1 SD) was 57.6\u2009\u00b1\u200914.7\u00a0years, with 52% male sex and 86% with type 2 diabetes. The ethnicity profile was 52% Black, 30% White, 10% Asian and 9% mixed\/other, with similar disease severity at the time of referral. Time-to-clinic was significantly longer for Asian people than for Black people (<jats:italic>p<\/jats:italic>\u2009=\u20090.03) or White people (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). Time-to-treatment was significantly longer for Black people than for White people (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). Social deprivation did not significantly influence time-to-treatment. There were no significant differences in the rates of vision loss between ethnic groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>Black people wait longer for hospital eye treatment compared with their White counterparts. The reasons for this delay in treatment warrant further investigation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-020-05364-5","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T15:03:07Z","timestamp":1611673387000},"page":"749-757","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Do Black and Asian individuals wait longer for treatment? A survival analysis investigating the effect of ethnicity on time-to-clinic and time-to-treatment for diabetic eye disease"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4322-1017","authenticated-orcid":false,"given":"Varo","family":"Kirthi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4112-4881","authenticated-orcid":false,"given":"Kate I.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-0664","authenticated-orcid":false,"given":"Ramith","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2427-0449","authenticated-orcid":false,"given":"Komeil","family":"Alattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-3713","authenticated-orcid":false,"given":"Catey","family":"Bunce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7618-1555","authenticated-orcid":false,"given":"Timothy L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,26]]},"reference":[{"issue":"9735","key":"5364_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet Lond Engl 376(9735):124\u2013136. https:\/\/doi.org\/10.1016\/S0140-6736(09)62124-3","journal-title":"Lancet Lond Engl"},{"issue":"3","key":"5364_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","volume":"35","author":"JWY Yau","year":"2012","unstructured":"Yau JWY, Rogers SL, Kawasaki R et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556\u2013564. https:\/\/doi.org\/10.2337\/dc11-1909","journal-title":"Diabetes Care"},{"issue":"7258","key":"5364_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321(7258):405\u2013412. https:\/\/doi.org\/10.1136\/bmj.321.7258.405","journal-title":"BMJ"},{"issue":"8","key":"5364_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.2337\/diacare.21.8.1230","volume":"21","author":"MI Harris","year":"1998","unstructured":"Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD (1998) Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 21(8):1230\u20131235. https:\/\/doi.org\/10.2337\/diacare.21.8.1230","journal-title":"Diabetes Care"},{"issue":"7","key":"5364_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/s0161-6420(02)01074-6","volume":"109","author":"R Klein","year":"2002","unstructured":"Klein R, Sharrett AR, Klein BEK et al (2002) The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 109(7):1225\u20131234. https:\/\/doi.org\/10.1016\/s0161-6420(02)01074-6","journal-title":"Ophthalmology"},{"issue":"3","key":"5364_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.ajo.2005.08.063","volume":"141","author":"TY Wong","year":"2006","unstructured":"Wong TY, Klein R, Islam FMA et al (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 141(3):446\u2013455. https:\/\/doi.org\/10.1016\/j.ajo.2005.08.063","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"5364_CR7","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/jamaophthalmol.2014.2854","volume":"132","author":"R Varma","year":"2014","unstructured":"Varma R, Bressler NM, Doan QV et al (2014) Prevalence of and risk factors for diabetic macular edema in the United States. JAMA Ophthalmol 132(11):1334\u20131340. https:\/\/doi.org\/10.1001\/jamaophthalmol.2014.2854","journal-title":"JAMA Ophthalmol"},{"key":"5364_CR8","unstructured":"National Eye Institute (2019) People with diabetes can prevent vision loss. Available from https:\/\/www.nei.nih.gov\/sites\/default\/files\/2019-06\/diabetes-prevent-vision-loss.pdf. Accessed 1 Aug 2020"},{"issue":"12","key":"5364_CR9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1001\/jama.1993.03500120075029","volume":"269","author":"KH Todd","year":"1993","unstructured":"Todd KH, Samaroo N, Hoffman JR (1993) Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 269(12):1537\u20131539. https:\/\/doi.org\/10.1001\/jama.1993.03500120075029","journal-title":"JAMA"},{"issue":"22","key":"5364_CR10","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1056\/NEJM199911253412206","volume":"341","author":"JZ Ayanian","year":"1999","unstructured":"Ayanian JZ, Cleary PD, Weissman JS, Epstein AM (1999) The effect of patients\u2019 preferences on racial differences in access to renal transplantation. N Engl J Med 341(22):1661\u20131669. https:\/\/doi.org\/10.1056\/NEJM199911253412206","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"5364_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1077558700057001S08","volume":"57","author":"LC Einbinder","year":"2000","unstructured":"Einbinder LC, Schulman KA (2000) The effect of race on the referral process for invasive cardiac procedures. Med Care Res Rev MCRR 57(Suppl 1):162\u2013180. https:\/\/doi.org\/10.1177\/1077558700057001S08","journal-title":"Med Care Res Rev MCRR"},{"key":"5364_CR12","doi-asserted-by":"publisher","unstructured":"Wilper AP, Woolhandler S, Lasser KE et al (2008) Waits to see an emergency department physician: U.S. trends and predictors, 1997-2004. Health Aff (Millwood) 27(2):w84\u2013w95. https:\/\/doi.org\/10.1377\/hlthaff.27.2.w84","DOI":"10.1377\/hlthaff.27.2.w84"},{"key":"5364_CR13","doi-asserted-by":"publisher","unstructured":"Harding S, Greenwood R, Aldington S et al (2003) Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 20(12):965\u2013971. https:\/\/doi.org\/10.1111\/j.1464-5491.2003.01077.x","DOI":"10.1111\/j.1464-5491.2003.01077.x"},{"key":"5364_CR14","unstructured":"Public Health England (2017) NHS Diabetic Eye Screening Programme: overview of patient pathway, surveillance pathways and referral pathways. Available from https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/648658\/Diabetic_Eye_Screening_pathway_overviews.pdf. Accessed 1 June 2020"},{"issue":"6","key":"5364_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1034\/j.1600-0420.1999.770613.x","volume":"77","author":"J Siderov","year":"1999","unstructured":"Siderov J, Tiu AL (1999) Variability of measurements of visual acuity in a large eye clinic. Acta Ophthalmol Scand 77(6):673\u2013676. https:\/\/doi.org\/10.1034\/j.1600-0420.1999.770613.x","journal-title":"Acta Ophthalmol Scand"},{"issue":"13","key":"5364_CR16","doi-asserted-by":"publisher","first-page":"9397","DOI":"10.1167\/iovs.11-7797","volume":"52","author":"N Shah","year":"2011","unstructured":"Shah N, Laidlaw DAH, Shah SP, Sivasubramaniam S, Bunce C, Cousens S (2011) Computerized repeating and averaging improve the test-retest variability of ETDRS visual acuity measurements: implications for sensitivity and specificity. Invest Ophthalmol Vis Sci 52(13):9397\u20139402. https:\/\/doi.org\/10.1167\/iovs.11-7797","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"5364_CR17","first-page":"163","volume":"55","author":"KJ Kerr","year":"2014","unstructured":"Kerr KJ, Genead MA, Wahlert AJ, Cheetham JK, Hashad Y (2014) Evaluation of the Test-Retest Reliability of the Electronic-ETDRS Visual Acuity Tester. Invest Ophthalmol Vis Sci 55(13):163\u2013163","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"5364_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.22599\/bioj.127","volume":"15","author":"MW Kan","year":"2019","unstructured":"Kan MW, Bjerre A (2019) The Test-Retest Variability of the COMPlog System in Participants with Induced Non-Normal Visual Acuity. Br Ir Orthopt J 15(1):47\u201352. https:\/\/doi.org\/10.22599\/bioj.127","journal-title":"Br Ir Orthopt J"},{"issue":"2","key":"5364_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/s0002-9394(02)01825-1","volume":"135","author":"RW Beck","year":"2003","unstructured":"Beck RW, Moke PS, Turpin AH et al (2003) A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol 135(2):194\u2013205. https:\/\/doi.org\/10.1016\/s0002-9394(02)01825-1","journal-title":"Am J Ophthalmol"},{"key":"5364_CR20","unstructured":"Office for National Statistics (2020) National Census Data. Available from https:\/\/www.ons.gov.uk\/census. Accessed 1 June 2020"},{"key":"5364_CR21","unstructured":"Public Health England (2017) NHS Diabetic Eye Screening Programme: grading definitions for referable disease. Available from https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/582710\/Grading_definitions_for_referrable_disease_2017_new_110117.pdf. Accessed 1 Jun 2020"},{"key":"5364_CR22","unstructured":"Diabetic Eye Screening Programme (2018) South-East London Diabetic Eye Screening Programme (DESP) Annual Data Summary. Available from https:\/\/www.guysandstthomas.nhs.uk\/our-services\/seldesp\/overview.aspx. Accessed 1 Feb 2019"},{"key":"5364_CR23","doi-asserted-by":"publisher","unstructured":"Hayward LM, Burden ML, Burden AC et al (2002) What is the prevalence of visual impairment in the general and diabetic populations: are there ethnic and gender differences? Diabet Med 19(1):27\u201334. https:\/\/doi.org\/10.1046\/j.0742-3071.2001.00603.x","DOI":"10.1046\/j.0742-3071.2001.00603.x"},{"issue":"3","key":"5364_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.eye.6700629","volume":"18","author":"S Pardhan","year":"2004","unstructured":"Pardhan S, Gilchrist J, Mahomed I (2004) Impact of age and duration on sight-threatening retinopathy in South Asians and Caucasians attending a diabetic clinic. Eye Lond Engl 18(3):233\u2013240. https:\/\/doi.org\/10.1038\/sj.eye.6700629","journal-title":"Eye Lond Engl"},{"issue":"6","key":"5364_CR25","doi-asserted-by":"publisher","first-page":"e39608","DOI":"10.1371\/journal.pone.0039608","volume":"7","author":"S Sivaprasad","year":"2012","unstructured":"Sivaprasad S, Gupta B, Gulliford MC et al (2012) Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK). PLoS One 7(6):e39608. https:\/\/doi.org\/10.1371\/journal.pone.0039608","journal-title":"PLoS One"},{"issue":"7","key":"5364_CR26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jfo.2014.11.015","volume":"38","author":"E Boulanger-Scemama","year":"2015","unstructured":"Boulanger-Scemama E, Querques G, About F et al (2015) Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting. J Fr Ophtalmol 38(7):620\u2013627. https:\/\/doi.org\/10.1016\/j.jfo.2014.11.015","journal-title":"J Fr Ophtalmol"},{"issue":"10","key":"5364_CR27","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s00417-019-04414-y","volume":"257","author":"R Angermann","year":"2019","unstructured":"Angermann R, Rauchegger T, Nowosielski Y et al (2019) Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 257(10):2119\u20132125. https:\/\/doi.org\/10.1007\/s00417-019-04414-y","journal-title":"Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"issue":"3","key":"5364_CR28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.oret.2018.11.002","volume":"3","author":"X Gao","year":"2019","unstructured":"Gao X, Obeid A, Aderman CM et al (2019) Loss to Follow-up After Intravitreal Anti-Vascular Endothelial Growth Factor Injections in Patients with Diabetic Macular Edema. Ophthalmol Retina 3(3):230\u2013236. https:\/\/doi.org\/10.1016\/j.oret.2018.11.002","journal-title":"Ophthalmol Retina"},{"key":"5364_CR29","doi-asserted-by":"publisher","unstructured":"Rauchegger T, Angermann R, Meusburger A et al (2020) Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-na\u00efve Patients with nAMD under Intravitreal Aflibercept Therapy. Klin Monatsbl Augenheilkd 237(6):789\u2013796. [Article in German]. https:\/\/doi.org\/10.1055\/a-1008-9357","DOI":"10.1055\/a-1008-9357"},{"issue":"6","key":"5364_CR30","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s40615-016-0316-y","volume":"4","author":"N Patel","year":"2017","unstructured":"Patel N, Ferrer HB, Tyrer F et al (2017) Barriers and Facilitators to Healthy Lifestyle Changes in Minority Ethnic Populations in the UK: a Narrative Review. J Racial Ethn Health Disparities 4(6):1107\u20131119. https:\/\/doi.org\/10.1007\/s40615-016-0316-y","journal-title":"J Racial Ethn Health Disparities"},{"key":"5364_CR31","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (2016) United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. Available from https:\/\/www.usrds.org\/annual-data-report\/. Accessed 1 Oct 2020"},{"issue":"4","key":"5364_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2105\/AJPH.92.4.543","volume":"92","author":"SA Black","year":"2002","unstructured":"Black SA (2002) Diabetes, Diversity, and Disparity: What Do We Do With the Evidence? Am J Public Health 92(4):543\u2013548. https:\/\/doi.org\/10.2105\/AJPH.92.4.543","journal-title":"Am J Public Health"},{"issue":"21","key":"5364_CR33","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1001\/archinte.162.21.2458","volume":"162","author":"G Corbie-Smith","year":"2002","unstructured":"Corbie-Smith G, Thomas SB, St George DMM (2002) Distrust, race, and research. Arch Intern Med 162(21):2458\u20132463. https:\/\/doi.org\/10.1001\/archinte.162.21.2458","journal-title":"Arch Intern Med"},{"issue":"7","key":"5364_CR34","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.2105\/AJPH.2005.080762","volume":"97","author":"K Armstrong","year":"2007","unstructured":"Armstrong K, Ravenell KL, McMurphy S, Putt M (2007) Racial\/ethnic differences in physician distrust in the United States. Am J Public Health 97(7):1283\u20131289. https:\/\/doi.org\/10.2105\/AJPH.2005.080762","journal-title":"Am J Public Health"},{"issue":"5","key":"5364_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1006\/jesp.1997.1329","volume":"33","author":"M Chen","year":"1997","unstructured":"Chen M, Bargh JA (1997) Nonconscious Behavioral Confirmation Processes: The Self-Fulfilling Consequences of Automatic Stereotype Activation. J Exp Soc Psychol 33(5):541\u2013560. https:\/\/doi.org\/10.1006\/jesp.1997.1329","journal-title":"J Exp Soc Psychol"},{"issue":"2","key":"5364_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2105\/ajph.93.2.248","volume":"93","author":"M van Ryn","year":"2003","unstructured":"van Ryn M, Fu SS (2003) Paved with good intentions: do public health and human service providers contribute to racial\/ethnic disparities in health? Am J Public Health 93(2):248\u2013255. https:\/\/doi.org\/10.2105\/ajph.93.2.248","journal-title":"Am J Public Health"},{"issue":"11","key":"5364_CR37","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1525-1497.2004.30227.x","volume":"19","author":"DJ Burgess","year":"2004","unstructured":"Burgess DJ, Fu SS, van Ryn M (2004) Why do providers contribute to disparities and what can be done about it? J Gen Intern Med 19(11):1154\u20131159. https:\/\/doi.org\/10.1111\/j.1525-1497.2004.30227.x","journal-title":"J Gen Intern Med"},{"issue":"10","key":"5364_CR38","doi-asserted-by":"publisher","first-page":"e1002942","DOI":"10.1371\/journal.pmed.1002942","volume":"16","author":"MB Whyte","year":"2019","unstructured":"Whyte MB, Hinton W, McGovern A et al (2019) Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis. PLoS Med 16(10):e1002942. https:\/\/doi.org\/10.1371\/journal.pmed.1002942","journal-title":"PLoS Med"},{"issue":"5","key":"5364_CR39","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/j.1475-6773.2004.00297.x","volume":"39","author":"FA Sloan","year":"2004","unstructured":"Sloan FA, Brown DS, Carlisle ES, Picone GA, Lee PP (2004) Monitoring visual status: why patients do or do not comply with practice guidelines. Health Serv Res 39(5):1429\u20131448. https:\/\/doi.org\/10.1111\/j.1475-6773.2004.00297.x","journal-title":"Health Serv Res"},{"key":"5364_CR40","unstructured":"Royal National Institute of Blind People (2018) Eye health and sight loss stats and facts. Available from https:\/\/www.rnib.org.uk\/eye-health-and-sight-loss-stats-and-facts. Accessed 1 June 2020"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-020-05364-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-020-05364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T11:09:58Z","timestamp":1615201798000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-020-05364-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,26]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5364"],"URL":"https:\/\/doi.org\/10.1007\/s00125-020-05364-5","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"type":"print","value":"0012-186X"},{"type":"electronic","value":"1432-0428"}],"subject":[],"published":{"date-parts":[[2021,1,26]]},"assertion":[{"value":"17 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}